COVID-19 Variant Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)
Zhang, Haibo |
Keenan Research Centre | Operating Grant | $50,000
CIHR Ontario 2021
Read More
COVID-19 Variant Supplement – The COVID‑19 Hospital Analytics Laboratory: Improving the Clinical, Organizational, and System Response to COVID-19
Verma, Amol |
Unity Health Toronto | Operating Grant | $50,000
CIHR Ontario 2021
Read More
COVID-19 Variant Supplement – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
Babu, Mohan |
The University of Regina | Operating Grant | $50,000
CIHR Saskatchewan 2021
Read More
Pulmonary vascular disease in patients with Long COVID
Weatherald, Jason |
The University of Calgary | Operating Grant | $292,092
CIHR Alberta 2021
Read More
COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals
Côté, Marceline |
University of Ottawa | Operating Grant | $50,000
CIHR Ontario 2021
Read More
Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID‑19 vaccines
Brockman, Mark A |
Simon Fraser University | Operating Grant | $495,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Neutralizing human-derived single-chain antibodies against SARS-CoV-2
Bach, Horacio |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
Remote Treatment of Alcohol Withdrawal: A Pilot Study
Sloan, Matthew E |
Centre for Addiction and Mental Health | Operating Grant | $186,152
CIHR Ontario 2020
Read More
Viral diversity and immune escape variants in vulnerable individuals post-vaccination.
Piccirillo, Ciriaco A |
McGill University | Operating Grant | $499,500
CIHR Quebec 2021
Read More
Prevention of the immunopathology induced by SARS-CoV-2
Estaquier, Jérôme |
Université Laval | Operating Grant | $499,800
CIHR Quebec 2021
Read More
